US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 5.1500
- -0.2400-4.45%
Trading Oct 15 10:29 ET
18.13MMarket Cap-2239P/E (TTM)
5.4100High5.1500Low3.78KVolume5.4100Open5.3900Pre Close19.98KTurnover0.23%Turnover RatioLossP/E (Static)3.52MShares8.650052wk High2.98P/B8.45MFloat Cap1.369552wk Low--Dividend TTM1.64MShs Float240.0000Historical High--Div YieldTTM4.82%Amplitude1.3695Historical Low5.2860Avg Price1Lot Size
About Monopar Therapeutics Company
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Company Profile
SymbolMNPR
Company NameMonopar Therapeutics
Listing DateDec 19, 2019
Issue Price8.00
Founded2014
CEODr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D.
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address1000 Skokie Boulevard,Suite 350
CityWilmette
ProvinceIllinois
CountryUnited States of America
Zip Code60091
Phone1-847-388-0349
Websitehttp://www.monopartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D.
- Chief Executive Officer and Director
- 1.78M
- Andrew J. Cittadine
- Chief Operating Officer
- 911.14K
- Karthik Radhakrishnan
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Patrice P. Rioux,M.D.,PhD
- Acting Chief Medical Officer
- --
- Dr. Christopher M. Starr,PhD
- Executive Chairman of the Board
- 264.04K
- Kim R. Tsuchimoto
- Director
- 848.44K
- Michael J. Brown, M. Sc.
- Independent Director
- 126.04K
- Arthur J. Klausner, M.B.A.
- Independent Director
- 128.54K
- Raymond William Anderson, M.B.A.,M.S.
- Independent Director
- 136.54K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data